November 23, 2021
OncoBone is pleased to announce signing a distributor agreement with a OsteoSys, a Korean-based company specialized in products for monitoring bone health in humans and animals. The distributor agreement covers Europe, with focus in Finland and Scandinavia.
Under the agreement, OncoBone will distribute iNSiGHT Dual-energy X-ray Absorptiometry (DXA), an easy-to-use, fast and non-invasive device for analyzing bone mineral density (BMD) and body composition in small animals in preclinical research.
Monet Hyungmin Lee, Sales Manager of OsteoSys says: “On behalf of OsteoSys, I am very pleased to announce a distributor agreement with OncoBone as our strategic business partner to officially distribute iNSiGHT, microDXA system, in Finland and Scandinavia. We are confident that OncoBone representatives as the authorized distributor of iNSiGHT can provide the very best service to our customers to aid research activities and to improve performance in the field of preclinical research.”
Tiina Kähkönen, CSO of OncoBone comments: “We are excited about the collaboration with OsteoSys. With a strong experience in using X-ray and DXA devices before, we are happy to acknowledge iNSiGHT as in our opinion the best DXA device for accurate and reliable measurement of BMD and body composition in small animals for scientists working in bone and metabolic disease fields.”
Contact us at email@example.com to learn more.